Oncotelic Therapeutics, Inc. Revenue from Contract with Customer, Excluding Assessed Tax
Oncotelic Therapeutics, Inc. (OTLC) reported Revenue from Contract with Customer, Excluding Assessed Tax of $1.74 million for the 12-month period ending 2020-12-31, per its 10-K filed 2022-04-15.
Discontinued › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2022-04-15
- Oncotelic Therapeutics, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2020-12-31 was $0.00.
- Oncotelic Therapeutics, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2020-09-30 was $0.00.
- Oncotelic Therapeutics, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2020-06-30 was $1.40M.
- Oncotelic Therapeutics, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2020-03-31 was $340.86K.
- Oncotelic Therapeutics, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2020 was $1.74M.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-15 | $0.00 derived: sum of 2 quarters · filed 2022-04-15 | $1.40M derived: sum of 3 quarters · filed 2022-04-15 | $1.74M 10-K · filed 2022-04-15 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-22 | $1.40M derived: sum of 2 quarters · filed 2021-11-22 | $1.74M 10-Q · filed 2021-11-22 | |
| 2020-06-30 | $1.40M 10-Q · filed 2021-08-20 | $1.74M 10-Q · filed 2021-08-20 | ||
| 2020-03-31 | $340.86K 10-Q · filed 2021-05-24 |